(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (JJ new) (NN method)) (PP (IN for) (NP (NN breast) (NN cancer) (VBG screening))) (PP (IN from) (NP (NNP DCE-MRI))) (VP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ post-hoc) (NN approach)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN trained) (PP (VBG using) (NP (NP (ADJP (RB weakly) (VBN annotated)) (NN data)) (PRN (-LRB- -LRB-) (WHADVP (JJ i.e.)) (, ,) (S (NP (NNS labels)) (VP (VBP are) (ADJP (JJ available)) (PP (ADVP (RB only)) (IN at) (NP (DT the) (NN image) (NN level))) (PP (IN without) (NP (DT any) (NN lesion) (NN delineation))))) (-RRB- -RRB-))))))))))))) (. .))
(S (S (NP (PRP$ Our) (VBN proposed) (NN post-hoc) (NN method)) (VP (ADVP (RB automatically)) (VBZ diagnosis) (NP (DT the) (JJ whole) (NN volume)))) (CC and) (, ,) (S (PP (IN for) (NP (JJ positive) (NNS cases))) (, ,) (NP (PRP it)) (VP (VBZ localizes) (NP (NP (DT the) (JJ malignant) (NNS lesions)) (SBAR (WHNP (WDT that)) (S (VP (VBD led) (PP (TO to) (NP (JJ such) (NN diagnosis))))))))) (. .))
(S (S (ADVP (RB Conversely)) (, ,) (NP (JJ traditional) (NNS approaches)) (VP (VBP follow) (NP (NP (DT a) (JJ pre-hoc) (NN approach)) (SBAR (WHNP (WDT that)) (S (ADVP (RB initially)) (VP (VBZ localises) (NP (NP (JJ suspicious) (NNS areas)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB subsequently)) (VP (VBN classified) (S (VP (TO to) (VP (VB establish) (NP (DT the) (NN breast) (NN malignancy)))))))))))))))) (: â€”) (S (NP (DT this) (NN approach)) (VP (VBZ is) (VP (VP (VBN trained) (S (VP (VBG using) (NP (ADJP (RB strongly) (VBN annotated)) (NN data))))) (PRN (-LRB- -LRB-) (INTJ (FW i.e.)) (, ,) (NP (PRP it)) (VP (VBZ needs) (NP (NP (DT a) (NN delineation) (CC and) (NN classification)) (PP (IN of) (NP (NP (DT all) (NNS lesions)) (PP (IN in) (NP (DT an) (NN image))))))) (-RRB- -RRB-))))) (. .))
(S (NP (NP (DT Another) (NN goal)) (PP (IN of) (NP (DT this) (NN paper)))) (VP (VBZ is) (S (VP (TO to) (VP (VB establish) (NP (NP (DT the) (NNS advantages) (CC and) (NNS disadvantages)) (PP (IN of) (NP (DT both) (NNS approaches))) (SBAR (WHADVP (WRB when)) (S (VP (VBN applied) (PP (TO to) (NP (NP (VB breast) (VBG screening)) (PP (IN from) (NP (NNP DCE-MRI))))))))))))) (. .))
(S (S (VP (VBG Relying) (PP (IN on) (NP (NP (NNS experiments)) (PP (IN on) (NP (NP (DT a) (NN breast) (NNP DCE-MRI) (NN dataset)) (SBAR (WHNP (WDT that)) (S (VP (VBZ contains) (NP (NP (NNS scans)) (PP (IN of) (NP (CD 117) (NNS patients))))))))))))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (JJ post-hoc) (NN method)) (VP (VBZ is) (ADJP (RBR more) (JJ accurate) (PP (IN for) (S (VP (VBG diagnosing) (NP (NP (DT the) (JJ whole) (NN volume)) (PP (IN per) (NP (NN patient)))))))) (, ,) (S (VP (VBG achieving) (NP (NP (DT an) (NNP AUC)) (PP (IN of) (NP (CD 0.91)))))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ pre-hoc) (NN method)) (VP (VBZ achieves) (NP (NP (DT an) (NNP AUC)) (PP (IN of) (NP (CD 0.81))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN performance)) (PP (IN for) (S (VP (VBG localising) (NP (DT the) (JJ malignant) (NNS lesions)))))) (VP (VBZ remains) (ADJP (VBG challenging)) (PP (IN for) (NP (DT the) (JJ post-hoc) (NN method))) (PP (JJ due) (TO to) (NP (NP (DT the) (ADJP (NN weakly) (VBD labelled)) (JJ dataset)) (VP (VBN employed) (PP (IN during) (NP (NN training))))))) (. .))
